Why it's good to share
No one said being a bio-entrepreneur would be easy. Raising sufficient finance to get started may be the first major hurdle, but finding suitable, affordable and fully-fitted premises is much harder than many realise.
The Milton Park story
The turn of the year is that traditional time to reflect on earlier successes and to anticipate future achievements. An appropriate time, then, to publish a book celebrating the vibrant life sciences cluster that has grown up on Milton Park, one of the largest mixed-use business estates in Europe.
Teaching your brain to breathe
Sleeping may be bad for your health — the wrong kind of sleep that is — according to Milton Park-based ResMed.
The business of science
It has been a long time coming but now research at Oxford University is finally starting to reap dividends. Immunocore, based at Milton Park, has landed a licensing agreement with biotech giant Genentech which will see it earn hundreds of millions of pounds over the coming years for its series of drugs called ImmTACs to treat cancer and viral disease.
